NuVasive tapped J. Christopher Barry to serve as CEO, replacing Gregory Lucier, effective Nov. 5.
Here are five things to know about the new CEO:
1. Mr. Barry previously served as Medtronic's senior vice president and president of the company's surgical innovations division.
2. As the president of Medtronic's surgical innovations division, Mr. Barry was responsible for the company's second-largest business unit, with $5.5 billion in annual revenue.
3. Mr. Barry spent 15 years at Covidien before the company was acquired by Medtronic for $50 billion in 2015.
4. At Covidien, Mr. Barry spent three years as vice president and general manager of U.S. energy-based devices. In this position, he led the development of the highest-growth region within the most lucrative business in Covidien.
5. Mr. Barry then went on to serve as president of advanced surgical technologies at Covidien. He was responsible for the $3.2 billion global business.